Working to facilitate rapid translation of scientific discoveries into therapeutics

Hélder A. Santos

Santos

Hélder A. Santos

Hélder A. Santos, PhD, is an Adjunct Professor of Pharmaceutical Nanotechnology at the Faculty of Pharmacy, University of Helsinki, and an Academy of Finland Research Fellow, University Researcher, and Principal Investigator/Group Leader at the Division of Pharmaceutical Technology, University of Helsinki. Dr. Santos’ research is focused on nanobiomaterials, including nanoporous silica/silicon materials, liposomes and solid lipid nanoparticles for controlled drug delivery, diagnostics, cardiovascular and diabetes diseases, immunotherapy and cancer therapy. In 2010, he received the “Talent Prize in Science” awarded by the Portuguese Government, and in 2012 received the ERC starting grant for 2013-2017 worth of 1.5 M€. He serves as a reviewer for more than 40 scientific international journals, as well as for the international research foundations The Leverhulme Trust, Research Foundation Flanders, The Swiss National Science Foundation, and The Netherlands Organisation for Scientific Research. Dr. Santos is the author of more than 70 refereed articles and he has acted as invited Guest Editor for Current Drug Discovery Technologies, Current Drug Metabolism and Biomatter journals. He is also an Editorial Board Member for the journals of Drug Delivery Letters, Biomatter, International Journal of Nanotechnology and Nanoscience, Pharmaceutical Nanotechnology, World Journal of Pharmacology, Journal of Biopharmaceutics and Biotechnology, BioMed Research International, and an Associate Editor for Versita. Dr. Santos is also the Editor of the journal Mesoporous Biomaterials journal and the Editor of a book entitled “Porous Silicon for Biomedical Applications”.

2013-2021©European Society for Translational Medicine (EUSTM)